The use of palliative protracted infusion 5FU (PVI 5FU) as first line treatment for metastatic oesophageal and gastric cancer patients not suitable for standard cisplatin based combination treatment

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Abdul RA, Fox V, Coxon F

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 9th World Congress on Gastrointestinal Cancer

Year of Conference: 2007

Pages: VII52-VII52

ISSN: 0923-7534

Publisher: Annals of Oncology, Oxford University Press

Library holdings: Search Newcastle University Library for this item

ISBN: 15698041

ePrints